proposed by the U.S. Environmental Protection Agency (EPA) indicates that the tetra-CDDs other than the 2,3,7,8 congener have a relative toxicity of0.01 compared to 2,3,7,8-TCDD, whereas the di-and trichlorinated PCDD isomers are considered to exhibit zero toxicity (4) .
Commercial use of2,4-D in the United States increased rapidly following World War 1 (3) . The 2,4-D amine and alkali salts and ester formulations are used to control the growth ofbroadleaf plants and weeds on range lands, lawns, golf courses, forests, roadways, parks, and agricultural land. 2,4-D is preferred over other herbicides for several reasons: low cost, effective action, and low acute toxicity. The various 2,4-D compounds are relatively mobile in most soils and are absorbed through both the roots and leaves of most plants, especially broadleaf species (5) .
The studies documenting potential human exposures to 2,4-D have focused on occupational cohorts and have identified the highest exposure levels in occupations involving the formulation or use of 2,4-D. Residential use of 2,4-D formulations typically produce much lower exposures than those observed in the occupational cohorts.
The studies completed for cohorts spraying 2,4-D and other phenoxy herbicides suggest that the level ofexposure is a direct function of the rate of application (3) . Individuals using backpack sprayers on right-of-ways receive the potentially highest daily personal exposures (3.4-4.9 mg/day) followed by helicopter and airplane application personnel (0.005-1.04 mg/day), farmers driving tractors (0.48 mg/day), and hand and tank commercial lawn sprayers (0.29 mg/day) (6) (7) (8) (9) . Variations in the estimated exposure levels are presumed to be based on the variable workplace setting and the amount of protective gear worn by the various occupational cohorts (3) . Estimates of the total lifetime doses are related directly to the number ofdays per year and the number ofyears of spraying activities. Experimental data from Grover et al. (7) and Lavy (10) indicate that exposure levels may be reduced by better workplace practices, such as wearing gloves and changing clothes following spraying activities. Although noncommercial applicators' exposure levels have not been studied, the homeowner who occasionally uses 2,4-D for domestic applications most likely receives daily doses and total lifetime exposures far lower than the occupational cohorts.
Toxicology
In this section, the toxicological evidence on 2,4-D is reviewed, including information on how the chemical is metabolized, its acute toxicity, the results from mutagenicity tests, and the findings from long-term carcinogen bioassays in animals. In performing this review, workshop participants relied primarily on recent reviews produced by the World Health Organization, the Canadian Centre for Toxicology, the International Agency for Research on Cancer, and the U.S. EPA Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) Scientific Advisory Panel (1, 3, 11, 12) . Virtually all of the toxicology studies have been done on the 2,4-D acid, and the assumption has been that these data apply to the 2,4-D esters and amines because these materials are readily metabolized to the acid.
Metabolism
Several reviews have been published regarding the absorption, distribution, metabolism, and excretion of2,4-D in humans and other mammals (1, 3, 13) . The salient metabolic information relevant to evaluating the current weight ofevidence of human carcinogenicity for 2,4-D is summarized below.
Data collected from occupational exposure studies indicate that 2,4-D may be absorbed at varying rates via the three classic exposure routes: inhalation, ingestion, and dermal absorption. Although the percent of2,4-D applied to the skin that is absorbed has been shown to be low in humans (5.8-6 .4%) compared to the dermal absorption of some other organic chemicals, the dermal absorption exposure route accounts for approximately 90% of the total absorbed dose of 2,4-D in workers who spray herbicides. The inhalation route of exposure is more important among workers who manufacture 2,4-D (1, 14, 15) .
Based on the results of ingestion uptake studies in human volunteers, 2,4-D administered in single doses is absorbed rapidly and completely (16) . Although uptake via inhalation of2,4-D in humans has been poorly studied, respiratory uptake in the rat indicates that 2,4-D is rapidly absorbed. Data from studies ofapplicators who spray 2,4-D indicate that respiratory exposures typically contribute only 2% ofthe total 2,4-D body burden (1, 7) .
Studies ofhuman subjects following oral exposure indicate that 2,4-D is rapidly absorbed and carried in the bloodstream throughout the entire body (16 
Acute Toxicity
The published laboratory animal studies on the acute toxicity of2,4-D indicate that it is a moderately toxic compound (1) .
The LD50 values for various 2,4-D analogs are highly dependent on the chosen animal species (1 Results from studies of2,4-D indicate that the dog has a subchronic no-observable-effect level (NOEL) of 10 mg/kg/day, and the rat has a NOEL of30 mg/kg/day (1) . A NOEL for reproductive effects in pregnant rats was observed at 10 mg/kg/day (1). Offspring exposed to higher 2,4-D doses in utero experienced decreased birth weight without apparent maternal toxicity.
The primary symptoms ofacute toxicity to 2,4-D exposure include damage to muscle tissue and the gastrointestinal tract and depression of the central nervous system (CNS) (3) . A study published recently, however, did not find any peripheral neuropathy effects in rats treated dermally for 3 weeks with a 12 % 2,4-D amine mixture and in rats treated for 2 weeks with a 24% 2,4-D acid mixture (17, 18 (23) . These dose groups were selected based on the results ofa 13-week subchronic study indicating that 60 mg/kg/day doses produced kidney damage, thereby satisfying the requirement of a maximum tolerated dose (MTD). The male rats in the highest exposed group experienced a statistically significant increase in a particular type of brain tumor (astrocytoma), as six rats with astrocytomas were observed upon autopsy over the 2-year period. Two astroytomas were detected in the 15 mg/kg/day male cohort; one such tumor was identified in the male controls. no statistically significant increases in the incidence ofbrain tumors were observed in the three groups of exposed male rats receiving the lowest doses or in any ofthe exposed groups of female Fischer rats.
In the second study, 4 groups of60 male and 60 female B6C3F, mice were exposed to oral doses of0, 1, 15, or 45 mg/kg/day of 2,4-D in their diet for 106 weeks (22) . No excess incidence of tumors was observed in any ofthe groups ofmale or female mice in this study.
Considered together, these two animal studies do not provide impressive evidence that exposure to 2,4-D causes cancer in animals. Based on the results from the rat study, the workshop participants concluded that there was weak evidence supporting an excess ofbrain cancer occurrence in the male Fischer 344 rats receiving the highest dose. The evidence of a relationship between 2,4-D exposure and brain cancer was considered weak for several reasons. First, the spontaneous incidence ofbrain tumors in rats in the control groups of other bioassays has been shown to be somewhat variable (24) . hence, there is some doubt about whether the excess incidence ofbrain tumors in the highest dose group of male rats is attributable to 2,4-D. (It should be noted, however, that most ofthe variability in brain tumor incidence was in strains other than Fischer 344.) Second, the female rats at the highest dose group did not exhibit an excess incidence of brain tumors. This is surprising because sex differences in metabolism, excretion, or permeation ofthe blood-brain barrier are not known to exist. Although the panel could not explain this observation, they speculated that in the male rat the dose of 45 mg/kg/day may saturate the capacity ofboth the kidney and the choroid plexus ofthe brain to excrete 2,4-D in rats at the higher doses. Several panel members stressed the importance of such a study. The additional carcinogenicity bioassay requested by the U.S. EPA (27, 28) , and Bond et al. (29) . In this report, we focus on those studies that are most relevant to assessing the weight of the evidence on the carcinogenicity of 2,4-D. We begin with the case-control studies because findings from several initial studies have largely driven the epidemiological research on phenoxy herbicides, including 2,4-D. The findings are summarized collectively at the end of the section.
Case-Control Studies
In a series of studies initiated in the late 1970s, Hardell obtain information onjob titles andjob activities, which the authors used to assign subjects to four categories ofexposure to phenoxy herbicides ("high," "medium," "low," or "no"' exposure). The likelihood of exposure to pesticides based on the respondents' job titles or activities was the sole determinant in assigning them to an exposure category. Subjects were also asked about their use of specific herbicides, including 2,4,5-T and 2,4-D.
Zahm et al. (43) applied the same methods used in the earlier Kansas study (40, 41 ) The findings by Woods et al. (42) provide weak evidence ofan association between phenoxy herbicides and NHL. In that study, four exposure categories were constructed based onjob title or job activity. When a specific job title given in an interview suggested possible exposure to phenoxy herbicides, additional questions were asked to ascertain exposure to specific chemicals including 2,4-D (42). It was not clear to workshop participants that this interview method could provide a study population whose exposure could be controlled for all chemicals other than 2,4-D. Exposure to phenoxy herbicides was associated with an OR of 1.07 (95% CI 0.8-1.4) in all the specified occupations and an OR of0.87 (95 % CI 0.5-1.5) among the entire study population. The OR increased to 1.71 (95% CI 1.04-2.8) among those with cumulative exposures to phenoxy herbicides of more than 15 years concluding at least 15 years before diagnosis. The authors found no association between the intensity ofphenoxy herbicide exposure and NHL using the four exposure categories. However, persons who worked regularly injobs involving spraying weeds in forests had an OR of 4.8 (95% CI 1.2-19.4). All of these forestry sprayers reported using 2,4-D and 2,4,5-T combined, as well as preparations containing other chemicals. In addition, firmers who used phenoxy herbicides also had an increased risk for NHL (OR = 1.33; 95% CI 1.03-1.7). Persons who reported using 2,4-D specifically had an OR of 0.73 (95% CI 0.4-1.3), although, as stated above, it is difficulttodetermine ifthis OR was controlled for other chemical exposures. The negative association between2,4-D use and NHLnmakesthispossible failureto control for other exposures less troubling, as confounding exposures would tend to increase, rather than decrease, the OR.
Pearce et al. (37, 38) reportedlitteorno evidenceofan association betweenuse ofphenoxy herbicides and NHL. The predominantphenoxy herbicide used in New Zealand is 2,4,5-T (35,37), andtheuseof2,4-D isnotwelldocumented inthese studies. There was no association between exposure to phenoxy herbicides and NHL, even forthose with probableordefiniteexposureofat least 5 days more than 10 years before diagnosis (using the pooled cohorts, OR = 1.4; 90% CI0.7-2.5). The specificoccupationsor activities involving potential exposuretophenoxy herbicides were also not associated with NHL. Anupdated reportby Pearce (39) found no association between NHL and frequency or duration of phenoxy herbicide use. The studies by Pearce Bond et al. (47) examined 878 chemical workers exposed to 2,4-D during the 1945 to 1982 period, with follow-up extending through 1982. Observed mortality was compared with expected levels based on adjusted rates for white males from the United States and for other employees from the same manufacturing location who were not exposed to 2,4-D. Analyses by production area, duration ofexposure, and cumulative dose showed no patterns suggestive ofa cause-effect relationship between 2,4-D exposure and any particular cause of death. No cases of brain cancer or STS were observed in the cohort. One death from HD was reported. There were two deaths from NHL compared to 0.5 expected. These two workers had potential for exposure to TCDD and hepta-or octa-PCDDs as well as 2,4-D. The authors noted that both cases ofNHL had moderate exposures to 2,4-D and that they had relatively short intervals (3 and 10.5 years) between first exposure to 2,4-D and death.
Lynge (44) examined cancer incidence among Danish workers employed in the manufucture ofphenoxy herbicides from 1964 through 1982. Cancer cases were identified by linkage with Denmark's National Cancer Register. The cohort was composed of 3390 males and 1069 females who were employed at one oftwo plants that manufactured herbicides (principally MCPA and, to a lesser extent, other phenoxys including 2,4-D) as well as a variety of other chemicals. Of the 4459 workers, 940 had been assigned to phenoxy herbicide operations. Expected numbers of cancer cases were calculated based on cancer incidence rates in the general Danish population. The highest estimated relative risk (RR) observed was for STS among males: 5 cases were observed versus 1.84 cases expected (estimated RR=2.72; 95% CI 0.88-6.34). Allowing for a 10-year latency period, four cases of STS were observed compared to 1.09 expected (estimated RR = 3.67; 95% CI 1.0-9.39). Three ofthe four STS cases had employment periods of 3 months or less, and the cases were not employed in occupations with high potential exposure to 2,4-D. (Only one case had been assigned to chlorophenoxy operations, and his total chemical plant employment was limited to 3 months.) For malignant lymphomas among males, there were 7 cases observed compared to 5.37 expected (estimated RR = 1.30; 95 % CI 0.52-2.69). When the author allowed for a 10-year latency period for malignant lymphoma, the estimated RR remained not statistically significant. None ofthe seven cases ofmalignant lymphoma occurred in the department producing phenoxy herbicides. The author believes her findings support Hardell's hypothesis of an association between STS and exposure to phenoxy herbicides not conaminated with 2,3,7,8-TCDD, but not Hardell's hypothesis ofan association between this exposure and HD or NHL. The study did not report an RR estimate specifically for 2,4-D exposure.
Wiklund et al. (49) examined a cohort of 20,245 Swedish pesticide appliers to assess whether HD and NHL are associated with exposure to phenoxy acid herbicides. All appliers had been licensed between 1965 and 1976, and 72 % of the appliers were estimated to have been exposed to phenoxy acid herbicides. In Sweden, MCPA was used much more frequently during this period than either 2,4-D or 2,4,5-T. The cohort was followed through the Swedish Cancer Register through 1982. The mean follow-up period was 12.2 years. A total of 11 cases with HD and 21 cases with NHL were observed compared to 9.1 and 20. Considered together, the three cohort studies provide weak to little evidence for an association between exposure to phenoxy herbicides (including 2,4-D) and human cancer. Each cancer type will be discussed separately.
The most provocative result is Lynge's finding of an estimated RR of 3.67 for STS after allowing for a 10-year latency (44) . However, MCPA and a variety of other chemicals are potential confounding exposures, and no RR estimate is reported specifically for 2,4-D. Moreover, it is noteworthy that three of the STS cases had less than 3 months of work experience at the plant, and several ofthe STS cases did not hold jobs with a high potential exposure to phenoxy herbicides. Bond et al. (47) found no cases of STS in their cohort, although less than one was expected.
The findings for HD in Wlddund et al. (49) suggest a weak positive association with use of phenoxy herbicides, but the associations are not statistically significant. Bond et al. (47) observed one death from HD in their cohort when less than one was expected. None of the studies reported an RRestimate specifically for 2,4-D exposure, and other chemicals, including other phenoxy herbicides, may have acted as confounders.
The findings for NHL, the end point ofgreatest interest in the case-control studies, are also unimpressive. Lynge (44) In summary, the cohort studies provide little evidence to suggest that 2,4-D exposure increases the risk for more common types ofcancer in humans. Evaluating their findings with regard to the less common cancers is more problematic because oftheir limited statistical power. These studies will provide more persuasive evidence in the future as the cohorts mature and the length of follow-up for mortality or cancer incidence increases. The workshop participants also noted that the NCI has several large cohort studies ofapplicator groups underway (i.e., studies of ChemLawn workers and Kansas Noxious Weed Department employees) and that these studies should be expected to contribute substantial information about the human carcinogenicity of 2,4-D.
Weight-of-Evidence Evaluation
There is no single correct way to integrate diverse kinds of data, especially when significant scientific uncertainties exist. In weighing the evidence on the human carcinogenicity of2,4-D, panel members had some differences in opinion, which we report, but these differences were not very great.
Workshop participants thought that it would be desirable to obtain more detailed information on the levels, duration, and frequency of 2,4-D exposure in the agricultural sector. If use of 2,4-D does cause any health problems, the weight ofthe available exposure information suggests that the problems will be most evident among those who produce, mix, or apply phenoxy herbicides in occupational settings.
The toxicological data reveal that 2,4-D is a chemical of moderate acute toxicity. Panel members found no indication that the human body's metabolism of2,4-D produces any particularly toxic metabolites.
2,4-D is unlikely to be a genotoxic carcinogen because it has been shown not to be mutagenic in most in vitro and in vivo systems. Moreover, the long-term animal bioassays of2,4-D in mice and rats have not produced impressive evidence of carcinogenicity, although the male rats in the highest dose group experienced a statistically significant increase in the risk ofbrain tumors relative to controls. Because the results for female rats were negative and because brain tumors tend to have a variable rate of spontaneous incidence in control rats, workshop participants were not convinced that a cause-effect relationship between 2,4-D exposure and brain tumors Workshop participants also reviewed several cohort studies that found no strong evidence ofan association between exposure to 2,4-D and non-Hodgkin's lymphoma. Although these studies were taken into account in the weight of the evidence, they had insufficient follow-up periods and, with the exception of Wiklund et al. (49) , insufficient sample sizes to negate the association suggested in the case-control studies. As more data on these cohorts is collected in the years ahead, they too may provide more definitive information.
In assessing all of the evidence on 2,4-D, workshop participants were not convinced that a cause-effect relationship between exposure to 2,4-D and human cancer exists. The NCI case-control studies from Kansas Workshop participants were asked to assess how likely it is, based on the available evidence, that exposure to 2,4-D causes cancer in humans. They were asked to respond with one of five answers: "known carcinogen," "probable carcinogen;' "possible carcinogen," "unlikely carcinogen," and "noncarcinogen." These terms were used in their ordinary sense by workshop participants and do not refer to the specific carcinogen classification categories used by the U.S. EPA, IARC, orby any other organization. None ofthe workshop participants thought the weight ofthe evidence indicated that 2,4-D was a "known" or "probable" cause ofhuman cancer. Most workshop participants (11 out of 13) responded that the available evidence suggests that it is "possible" that 2,4-D can cause cancer in humans. Not all of these 11 participants thought the possibility was equally likely; one participant thought the possibility was relatively strong, leaning toward "probable" and five thought the possibility was relatively remote, leaning toward "unlikely." A minority oftwo participants thought, based on the weight ofthe evidence, that it was unlikely that 2,4-D can cause cancer in humans. Several panel members expressed the opinion that the available evidence was barely adequate to support any conclusion at this time.
In light ofthe possible cause-effect relationship between the use of2,4-D and non-Hodgkin's lymphoma, the magnitude ofthe 1potential public health problem should be assessed. The ageadjusted incidence ofnon-Hodgkin's lymphoma is 12 cases per 100,000 person-years, and the highest human exposure levels occur in selected occupational settings. The available evidence also suggests that the risk ofcontracting non-Hodgkin's lymphoma, assuming a cause-effect relationship with 2,4-D, can be reduced if workers wear protective equipment during mixing and ap-plying herbicides and change clothing immediately after exposure to herbicides. The panelists were encouraged to learn that manufacturers are currently testing alternative delivery systems for 2,4-D which, ifsuccessful, would greatly reduce the potential for applicator exposure.
